The RBC as a Target of Damage

Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms

Volumn , Issue , 2014, Pages 3068-3080

  Hendrickson, J E ^a   Tormey, C A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Alloantibody; Autoantibody; Complement; Direct antiglobuLin test; Extravascular; Hemolysis; Hemolytic disease of the fetus and newborn (HDFN); IgG; IgM; Indirect antiglobuLin test; Intravascular; RBC antigen; Red blood cell; Transfusion

Indexed keywords

EID: 85043240951     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-386456-7.06203-1     Document Type: Chapter

References (30)

1. Bao W., Yu J., Heck S., Yazdanbakhsh K. Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood 2009, 113:5624-5627.
2. Baudino L., Azeredo da Silveira S., Nakata M., Izui S. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer Semin. Immunopathol. 2006, 28:175-184.
3. Brinc D., Lazarus A.H. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. Hematology Am. Soc. Hematol. Educ. Program 2009 2009, 185-191.
4. Fagiolo E., Toriani-Terenzi C. Mechanisms of immunological tolerance loss versus erythrocyte self-antigens and autoimmune hemolytic anemia. Autoimmunity 2003, 36:199-204.
5. Fossati-Jimack L., Ioan-Facsinay A., Reininger L., Chicheportiche Y., Watanabe N., Saito T., et al. Markedly different pathogenicity of four immunoglobuLin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J. Exp. Med. 2000, 191:1293-1302.
6. Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin. Drug Saf. 2012, 11:635-642.
7. Hendrickson J.E., Desmarets M., Deshpande S.S., Chadwick T.E., Hillyer C.D., Roback J.D., et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006, 46:1526-1536.
8. Hod E.A., Arinsburg S.A., Francis R.O., Hendrickson J.E., Zimring J.C., Spitalnik S.L. Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sang. 2010, 99:99-111.
9. Hudson K.E., Hendrickson J.E., Cadwell C.M., Iwakoshi N.N., Zimring J.C. Partial tolerance of autoreactive B and T cells to erythrocyte-specificself-antigens in mice. Haematologica 2012, 97(12):1836-1844.
10. Kumpel B.M. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn. CLin. Exp. Immunol. 2008, 154:1-5.
11. Lee A.I., Kaufman R.M. Transfusion medicine and the pregnant patient. Hematol. Oncol. CLin. North Am. 2011, 25:393-413.
12. Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev. Hematol. 2011, 4:607-618.
13. Moise K.J., Rodkey L.S., Yared M., Hudon L., Saade G., Dorman K., et al. An animal model for hemolytic disease of the fetus or newborn in New Zealand white and New Zealand red rabbits: newborn effects. Am. J. Obstet. Gynecol. 1998, 179:1353-1358.
14. Okamoto M., Murakami M., Shimizu A., Ozaki S., Tsubata T., Kumagai S., et al. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 1992, 175:71-79.
15. Reviron D., Dettori I., Ferrera V., Legrand D., Touinssi M., Mercier P., et al. HLA-DRB1 alleles and Jk(a) immunization. Transfusion 2005, 45:956-959.
16. Technical Manual 2011, AABB Press, Bethesda, MD. seventeenth ed. J.D. Roback, B.J. Grossman, T. Harris, C.D. Hillyer (Eds.).
17. Smith R.N., Amsden A., Sudilovsky O., Coleman N., MargoLies R. The alloantibody response in the allogeneically pregnant rat. IV. Analysis of the alloantibody specificities with monoclonal antibodies. J. Immunol. 1986, 136:4063-4069.
18. Smith N.H., Hod E.A., Spitalnik S.L., Zimring J.C., Hendrickson J.E. Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood 2012, 119:1566-1569.
19. Storry J.R., Olsson M.L. The ABO blood group system revisited: a review and update. Immunohematology 2009, 25:48-59.
20. Stowell S.R., Winkler A.M., Maier C.L., Arthur C.M., Smith N.H., Girard-Pierce K.R., et al. Initiation and regulation of complement during hemolytic transfusion reactions. CLin. Dev. Immunol. 2012, 2012:307093.
21. Stowell, S.R., Girard-Pierce, K.R., Smith, N.H., Henry, K.L., Arthur, C.M., Zimring, J.C., et al., 2013. Transfusion of murine red blood cells expressing the human KEl glycoprotein induces cLinically significant alloantibodies. Transfusion. [Epub ahead of press].
22. Tormey C.A., Stack G. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009, 114:4279-4282.
23. Tormey C.A., Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009, 49:505-512.
24. Tormey C.A., Fisk J., Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male miLitary veterans. Transfusion 2008, 48:2069-2076.
25. Torres R., Kenney B., Tormey C.A. Diagnosis, treatment and reporting of adverse effects of transfusion. LabMedicine 2012, 43:217-231.
26. Urbaniak S.J. Alloimmunity to human red blood cell antigens. Vox Sang. 2002, 83(Suppl. 1):293-297.
27. Urbaniak S.J. Alloimmunity to RhD in humans. Transfus. CLin. Biol. 2006, 13:19-22.
28. Yazdanbakhsh K., Ware R.E., Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012, 120:528-537.
29. Yousaf N., Howard J.C., WilLiams B.D. Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance. CLin. Exp. Immunol. 1986, 66:654-660.
30. Yu J., Heck S., Yazdanbakhsh K. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am. J. Hematol. 2007, 82:691-696.